US1044508A
(en)
*
|
1911-04-21 |
1912-11-19 |
Ajax Forge Company |
Railway-frog.
|
BE789948A
(fr)
|
1971-10-13 |
1973-04-11 |
Sandoz Sa |
Nouveaux derives du pyrazole, leur preparation et leur application comme medicaments
|
JPS5113156B2
(es)
|
1972-10-21 |
1976-04-26 |
|
|
US4016037A
(en)
|
1975-10-15 |
1977-04-05 |
Ajinomoto Co., Inc. |
Method for producing L-amino acid
|
US4110536A
(en)
|
1977-04-18 |
1978-08-29 |
Miles Laboratories, Inc. |
Derivatives of 5-(indol-3-yl)hydantoin
|
DE2728523C2
(de)
|
1977-06-23 |
1986-02-27 |
Schering AG, 1000 Berlin und 4709 Bergkamen |
4-Methyl-1,2,3-thiadiazol-5-carbonsäure-(cyclohexylmethyl)-amid, Mittel mit herbizider und wachstumsregulatorischer Wirkung enthaltend diese Verbindung sowie Verfahren zu seiner Herstellung
|
JPS55136279A
(en)
|
1979-04-09 |
1980-10-23 |
Ajinomoto Co Inc |
Preparation of tryptophan hydantoin
|
JPS5810074B2
(ja)
|
1979-07-18 |
1983-02-24 |
味の素株式会社 |
新規微生物
|
GB2080803B
(en)
|
1980-07-28 |
1984-01-18 |
Pfizer |
Hypoglycemic 5-substituted oxazolidine-2,4-diones
|
US4332952A
(en)
|
1980-07-28 |
1982-06-01 |
Pfizer Inc. |
Hypoglycemic 5-substituted oxazolidine-2,4-diones
|
DE3567460D1
(en)
|
1984-06-07 |
1989-02-16 |
Pfizer Ltd |
Dihydropyridines
|
JPS6122081A
(ja)
|
1984-07-10 |
1986-01-30 |
Mitsui Toatsu Chem Inc |
ヒダントイン化合物の製造法
|
US4684735A
(en)
|
1985-07-01 |
1987-08-04 |
Stauffer Chemical Company |
Promotion of raney nickel hydrogenation catalyst
|
JPH0623148B2
(ja)
|
1985-09-05 |
1994-03-30 |
三井東圧化学株式会社 |
N−アセチル−dl−アミノ酸の製造方法
|
DE3685626T2
(de)
|
1985-09-26 |
1993-01-28 |
Beckmann Research Inst Of The |
Sequenzierung von peptiden.
|
JPH0659227B2
(ja)
|
1985-11-08 |
1994-08-10 |
三井東圧化学株式会社 |
D−α−アミノ酸の製造方法
|
JPS6225990A
(ja)
|
1986-07-19 |
1987-02-03 |
Kanegafuchi Chem Ind Co Ltd |
D−α−アミノ酸類の製造方法
|
US4705864A
(en)
|
1986-11-10 |
1987-11-10 |
The Standard Oil Company |
Aryl oxime derivatives of hydantoins
|
US4911931A
(en)
|
1987-08-03 |
1990-03-27 |
Baylink David J |
Pharmaceutical combination for treatment of bone-wasting diseases
|
JP2661111B2
(ja)
|
1988-03-09 |
1997-10-08 |
三菱化学株式会社 |
D−N−カルバミル−α−アミノ酸の製造法
|
US4868061A
(en)
|
1988-05-19 |
1989-09-19 |
The Standard Oil Company |
Olefinic aryl oxime derivatives of hydantoins
|
IE62214B1
(en)
|
1988-05-25 |
1995-01-11 |
Warner Lambert Co |
Arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and antiinflammatory agents
|
JPH0219363A
(ja)
|
1988-07-06 |
1990-01-23 |
Fujisawa Pharmaceut Co Ltd |
イミダゾリジン誘導体
|
WO1990004183A1
(en)
|
1988-10-07 |
1990-04-19 |
Commonwealth Scientific And Industrial Research Organisation |
Method for preparation of thiohydantoins and for protein sequence analysis
|
EP0377083B1
(de)
|
1989-01-02 |
1993-09-22 |
Rütgerswerke Aktiengesellschaft |
Verfahren zur Herstellung von L-alpha-Aminosäuren
|
JPH054910A
(ja)
|
1990-07-31 |
1993-01-14 |
Nikka Chem Co Ltd |
化粧料組成物
|
KR100222634B1
(ko)
|
1990-08-31 |
1999-10-01 |
로즈 암스트롱, 크리스틴 에이. 트러트웨인 |
콜레시스토키닌길항제,그의제조방법및치료학적용도
|
JP2651755B2
(ja)
|
1991-03-01 |
1997-09-10 |
富士写真フイルム株式会社 |
ハロゲン化銀カラー写真感光材料
|
NZ286242A
(en)
|
1991-03-26 |
1997-11-24 |
Csl Ltd |
Use of veterinary implant as a single dose vaccination system: rupturable polymer film coating around core of active agent and water soluble excipient
|
US5693643A
(en)
|
1991-09-16 |
1997-12-02 |
Merck & Co., Inc. |
Hydantoin and succinimide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists
|
DE69223573D1
(de)
|
1991-09-16 |
1998-01-29 |
Merck & Co Inc |
Hydantoin und Succinimid-substituierte Spiroindanylcamphorsulfonyl als Oxytocin-Antagonisten
|
CA2083891A1
(en)
|
1991-12-03 |
1993-06-04 |
Angus Murray Macleod |
Heterocyclic compounds, compositions containing them and their use in therapy
|
JP3163361B2
(ja)
|
1992-03-12 |
2001-05-08 |
味の素株式会社 |
5−アルキルヒダントイン誘導体の製造法
|
US5574030A
(en)
|
1992-07-14 |
1996-11-12 |
Nippon Chemiphar Co., Ltd. |
N-aminoalkyl-substituted nitrogen-containing five membered heterocyclic compounds
|
ES2121036T3
(es)
|
1992-07-14 |
1998-11-16 |
Nippon Chemiphar Co |
Derivados de alquilenodiamina.
|
US5830854A
(en)
|
1992-12-14 |
1998-11-03 |
Merck Sharp & Dohme, Limited |
Method of treating cystic fibrosis using a tachykinin receptor antagonist
|
US5338859A
(en)
|
1993-02-12 |
1994-08-16 |
Hoechst Celanese Corporation |
Process for the production of calcium salts of hydantoic acids
|
EP0640594A1
(en)
|
1993-08-23 |
1995-03-01 |
Fujirebio Inc. |
Hydantoin derivative as metalloprotease inhibitor
|
JPH10505597A
(ja)
|
1994-09-08 |
1998-06-02 |
イーライ・リリー・アンド・カンパニー |
興奮性アミノ酸レセプターアンタゴニスト
|
WO1996030393A1
(en)
|
1995-03-27 |
1996-10-03 |
Warner-Lambert Company |
A method for the synthesis of mixtures of compounds
|
US6166054A
(en)
|
1995-03-31 |
2000-12-26 |
Nihon Nohyaku Co., Ltd. |
Agricultural and horticultural disease controller and a method for controlling the diseases
|
US5674734A
(en)
|
1995-05-18 |
1997-10-07 |
President And Fellows Of Harvard College |
Cell death protein
|
DE19519717C1
(de)
|
1995-05-30 |
1996-08-22 |
Degussa |
Neuer Mikroorganismus, dessen Verwendung und Verfahren zur Herstellung von L-alpha-Aminosäuren
|
US6846839B1
(en)
|
1995-06-07 |
2005-01-25 |
Sugen, Inc. |
Methods for treating diseases and disorders related to unregulated angiogenesis and/or vasculogenesis
|
US5962478A
(en)
|
1995-09-19 |
1999-10-05 |
Margolin; Solomon B. |
Inhibition of tumor necrosis factor α
|
WO1997015586A1
(en)
|
1995-10-23 |
1997-05-01 |
Tularik, Inc. |
Rip: novel human protein involved in tumor necrosis factor signal transduction, and screening assays
|
AU722421B2
(en)
|
1996-04-24 |
2000-08-03 |
Novo Nordisk A/S |
Compounds with growth hormone releasing properties
|
WO1998014437A1
(fr)
|
1996-09-30 |
1998-04-09 |
Nihon Nohyaku Co., Ltd. |
Derives de 1,2,3-thiadiazole et sels de ces derives, agents en usage dans l'agriculture et l'horticulture pour lutter contre les maladies vegetales, et procede d'utilisation correspondant
|
US5859190A
(en)
|
1997-02-04 |
1999-01-12 |
Trega Biosciences, Inc. |
Combinatorial libraries of hydantoin and thiohydantoin derivatives, methods of making the libraries and compounds therein
|
CA2278547A1
(en)
|
1997-03-03 |
1998-09-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Small molecules useful in the treatment of inflammatory disease
|
IL126024A0
(en)
|
1998-03-19 |
1999-05-09 |
Yeda Res & Dev |
Modulators of the function of receptors of the tnf/ngf receptor family and other proteins
|
ATE238661T1
(de)
|
1998-07-30 |
2003-05-15 |
Nihon Nohyaku Co Ltd |
Fungizide zusammensetzung enthaltend ein 1,2,3- thiadiazolderivat sowie deren verwendung
|
DE59905623D1
(de)
|
1998-09-22 |
2003-06-26 |
Degussa |
Verfahren zur Herstellung von Imidazolidin-2,4-dionen
|
US6020198A
(en)
|
1998-09-25 |
2000-02-01 |
Isis Pharmaceuticals Inc. |
Antisense modulation of RIP-1 expression
|
AU754989B2
(en)
|
1998-11-16 |
2002-11-28 |
Nippon Zoki Pharmaceutical Co., Ltd. |
A therapeutic agent for intractable vasculitis
|
US6353013B1
(en)
|
1999-07-21 |
2002-03-05 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Small molecules useful in the treatment of inflammatory disease
|
WO2001007048A1
(en)
|
1999-07-21 |
2001-02-01 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Small molecules useful in the treatment of inflammatory disease
|
US6756394B1
(en)
|
1999-10-15 |
2004-06-29 |
President And Fellow Of Harvard College |
Small molecule inhibitors of necrosis
|
WO2001028493A2
(en)
|
1999-10-15 |
2001-04-26 |
President And Fellows Of Harvard College |
Small molecule inhibitors of necrosis
|
US6706766B2
(en)
|
1999-12-13 |
2004-03-16 |
President And Fellows Of Harvard College |
Small molecules used to increase cell death
|
AU2001244596A1
(en)
|
2000-03-30 |
2001-10-15 |
Rei Asakai |
Indolylpyrrole derivatives and cell death inhibitors
|
US20020155172A1
(en)
|
2000-04-07 |
2002-10-24 |
Junying Yuan |
Methods and compounds for decreasing cell toxicity or death
|
GB0011071D0
(en)
|
2000-05-08 |
2000-06-28 |
Novartis Ag |
Organic compounds
|
US6846643B2
(en)
|
2000-08-14 |
2005-01-25 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Methods and molecules useful for identifying molecules that bind LFA-1 and for determining receptor occupancy
|
US20020064736A1
(en)
|
2000-09-27 |
2002-05-30 |
Fuji Photo Film Co., Ltd. |
Dye-forming coupler, silver halide photographic light-sensitive material, and method for producing an azomethine dye
|
JP2002145192A
(ja)
|
2000-11-07 |
2002-05-22 |
Yamaha Motor Co Ltd |
水上乗物の燃料タンク構造
|
JP4529338B2
(ja)
|
2001-03-08 |
2010-08-25 |
味の素株式会社 |
ヒダントイナーゼをコードするdna、n−カルバミル−l−アミノ酸ハイドロラーゼをコードするdna、組み換えdna、形質転換された細胞、タンパク質の製造方法および光学活性アミノ酸の製造方法
|
MXPA04002404A
(es)
|
2001-09-14 |
2004-05-31 |
Novo Nordisk As |
Ligandos novedosos para los sitios hisb10zn2+ del hexamero de insulina en estado r.
|
WO2003042234A2
(en)
|
2001-11-14 |
2003-05-22 |
Novartis Ag |
Non-peptide somatostatin receptor ligands
|
PL370636A1
(en)
|
2001-11-22 |
2005-05-30 |
Ono Pharmaceultical Co, Ltd. |
Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient
|
US6797708B2
(en)
|
2001-12-03 |
2004-09-28 |
Wyeth |
Inhibitors of cytosolic phospholipase A2
|
JP3659224B2
(ja)
|
2001-12-26 |
2005-06-15 |
村田機械株式会社 |
インターネットファクシミリ装置
|
WO2003057214A1
(en)
|
2001-12-28 |
2003-07-17 |
Somatocor Pharmaceuticals, Inc. |
Imidazolidin-2,4-dione derivatives as non-peptide somatostatin receptor ligands
|
US7379820B2
(en)
|
2002-02-11 |
2008-05-27 |
Wyeth |
Solution structure of RIP DD and uses thereof
|
CA2497880A1
(en)
|
2002-09-06 |
2004-03-18 |
Mount Sinai Hospital |
Methods for assaying protein-protein interactions
|
CA2506630A1
(en)
|
2002-11-27 |
2004-06-17 |
Artesian Therapeutics, Inc. |
Heart failure gene determination and therapeutic screening
|
ES2297227T3
(es)
|
2002-12-20 |
2008-05-01 |
Novo Nordisk A/S |
Composiciones farmaceuticas conteniendo insulina y ligandos del hexamero de insulina.
|
FR2850652B1
(fr)
|
2003-01-31 |
2008-05-30 |
Aventis Pharma Sa |
Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
GB0302671D0
(en)
|
2003-02-06 |
2003-03-12 |
Astrazeneca Ab |
Pharmaceutical formulations
|
US7320986B2
(en)
|
2003-03-07 |
2008-01-22 |
Abbott Labortories |
Fused tri and tetra-cyclic pyrazole kinase inhibitors
|
EP1610812A1
(en)
|
2003-03-11 |
2006-01-04 |
Novo Nordisk A/S |
Pharmaceutical preparations comprising acid-stabilised insulin
|
EP1605967A1
(en)
|
2003-03-13 |
2005-12-21 |
Novo Nordisk A/S |
Novel nph insulin preparations
|
CA2536622C
(en)
|
2003-08-29 |
2014-02-11 |
The Brigham And Women's Hospital, Inc. |
Inhibitors of cellular necrosis
|
JP4452914B2
(ja)
|
2003-09-08 |
2010-04-21 |
味の素株式会社 |
新規トランスポータタンパク質
|
WO2005028664A2
(en)
|
2003-09-17 |
2005-03-31 |
University Of Massachusetts |
Modulation of programmed necrosis
|
DE10342839A1
(de)
|
2003-09-17 |
2005-04-28 |
Symrise Gmbh & Co Kg |
Thiohydantoine zur Aufhellung von Haut oder Haar
|
US6887993B1
(en)
|
2003-11-12 |
2005-05-03 |
Kosan Biosciences, Inc. |
11-O-methylgeldanamycin compounds
|
WO2005080372A1
(en)
|
2004-02-19 |
2005-09-01 |
Bayer Healthcare Ag |
Dihydropyridinone derivatives
|
US7935510B2
(en)
|
2004-04-30 |
2011-05-03 |
Intrexon Corporation |
Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
|
GB0410379D0
(en)
|
2004-05-11 |
2004-06-16 |
Univ Leicester |
Treatment of cancer
|
AU2005266890C1
(en)
|
2004-07-30 |
2014-09-25 |
Exelixis, Inc. |
Pyrrole derivatives as pharmaceutical agents
|
US7595337B2
(en)
|
2005-02-10 |
2009-09-29 |
Merck & Co. Inc. |
Mitotic kinesin inhibitors
|
WO2006103995A1
(ja)
|
2005-03-25 |
2006-10-05 |
Kaneka Corporation |
光学活性α-アミノ酸誘導体の製造方法
|
WO2007024944A1
(en)
|
2005-08-25 |
2007-03-01 |
Schering Corporation |
Imidazole derivatives as functionally selective alpha2c adrenoreceptor agonists
|
AU2006303955A1
(en)
|
2005-10-11 |
2007-04-26 |
Intermune, Inc. |
Inhibitors of viral replication
|
US7531671B2
(en)
|
2005-11-01 |
2009-05-12 |
Janssen Pharmaceutica N.V. |
Dihydroisoindolones as allosteric modulators of glucokinase
|
AU2006331754B9
(en)
|
2005-12-20 |
2013-07-11 |
President And Fellows Of Harvard College |
Compounds, screens, and methods of treatment
|
AR056882A1
(es)
|
2006-02-01 |
2007-10-31 |
Bayer Cropscience Sa |
Derivados del fungicida n- cicloalquil- bencil- amida
|
US8007790B2
(en)
|
2006-04-03 |
2011-08-30 |
Stowers Institute For Medical Research |
Methods for treating polycystic kidney disease (PKD) or other cyst forming diseases
|
CA2658223A1
(en)
|
2006-07-13 |
2008-01-17 |
4Sc Ag |
Benzopyranopyrazoles
|
CA2666060C
(en)
|
2006-10-10 |
2015-02-03 |
President And Fellows Of Harvard College |
Thieno[2,3-d]pyrimidin-4-one compounds and methods of using the same
|
CN101679295A
(zh)
|
2007-06-06 |
2010-03-24 |
帝斯曼知识产权资产管理有限公司 |
新颖的被5-取代的乙内酰脲
|
WO2009023272A1
(en)
|
2007-08-15 |
2009-02-19 |
President And Fellows Of Harvard College |
Heterocyclic inhibitors of necroptosis
|
EP2543368A1
(en)
|
2007-12-11 |
2013-01-09 |
Viamet Pharmaceuticals, Inc. |
Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
|
JP2011512132A
(ja)
|
2008-02-14 |
2011-04-21 |
エフ.ホフマン−ラ ロシュ アーゲー |
骨髄毒性の予測方法
|
US20120061324A1
(en)
*
|
2008-03-28 |
2012-03-15 |
Global Material Technologies, Inc. |
Element removal process and apparatus
|
US8304421B2
(en)
|
2008-09-30 |
2012-11-06 |
Vanderbilt University |
Indole compounds and their use as radiation sensitizing agents and chemotherapeutic agents
|
WO2010075290A1
(en)
|
2008-12-22 |
2010-07-01 |
President And Fellows Of Harvard College |
Unsaturated heterocyclic inhibitors of necroptosis
|
US20120122889A1
(en)
|
2008-12-23 |
2012-05-17 |
President And Fellows Of Harvard College |
Small molecule inhibitors of necroptosis
|
JP2010202575A
(ja)
|
2009-03-03 |
2010-09-16 |
Takeda Chem Ind Ltd |
複素環化合物
|
DE102009002044A1
(de)
|
2009-03-31 |
2010-10-07 |
Evonik Degussa Gmbh |
Dipeptide als Futtermitteladditive
|
JP5332882B2
(ja)
|
2009-04-30 |
2013-11-06 |
豊田合成株式会社 |
半導体発光素子
|
JP2010275229A
(ja)
|
2009-05-28 |
2010-12-09 |
Ikutoku Gakuen |
ヒダントイン誘導体
|
EP2519517B1
(en)
|
2009-12-29 |
2015-03-25 |
Dana-Farber Cancer Institute, Inc. |
Type ii raf kinase inhibitors
|
AR080234A1
(es)
|
2010-02-25 |
2012-03-21 |
Marrone Bio Innovations Inc |
Cepa bacteriana aislada del genero burkholderia y metabolitos pesticidas del mismo
|
EA201290919A1
(ru)
|
2010-03-16 |
2013-03-29 |
Дана-Фарбер Кэнсер Инститьют, Инк. |
Индазольные соединения и их применение
|
JP2013523766A
(ja)
|
2010-03-31 |
2013-06-17 |
グラクソ グループ リミテッド |
キナーゼ阻害剤としてのイミダゾリル‐イミダゾール
|
US20130137642A1
(en)
|
2010-04-23 |
2013-05-30 |
Demetrios Vavvas |
Methods and compositions for preserving photoreceptor and retinal pigment epithelial cells
|
US20140024598A1
(en)
|
2010-11-01 |
2014-01-23 |
Demetrios Vavvas |
Methods and compositions for preserving retinal ganglion cells
|
AU2012225506B2
(en)
|
2011-03-07 |
2016-11-17 |
The Ohio State University |
Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer
|
US9746470B2
(en)
|
2011-05-09 |
2017-08-29 |
Whitehead Institute For Biomedical Research |
Chaperone interaction assays and uses thereof
|
CN102850252B
(zh)
|
2011-06-30 |
2014-08-13 |
山东大学 |
一种3,5,5’-三取代乙内酰脲的制备方法
|
WO2013013826A1
(en)
|
2011-07-27 |
2013-01-31 |
Friedrich-Alexander-Universität Erlangen-Nürnberg |
Necroptosis inhibitors for the treatment of inflammatory diseases of the gastrointestinal tract
|
US9314328B2
(en)
|
2011-08-16 |
2016-04-19 |
W. L. Gore & Associates, Inc. |
Branched stent graft device and deployment
|
JP5961693B2
(ja)
|
2011-08-27 |
2016-08-02 |
マローネ バイオ イノベーションズ,インコーポレイテッド |
ブルクホルデリア(Burkholderia)属の単離細菌株及びそれに由来する殺有害生物性代謝物の製剤及び使用
|
US20140357570A1
(en)
*
|
2011-10-21 |
2014-12-04 |
Massachusetts Eye And Ear Infirmary |
Compositions comprising necrosis inhibitors, such as necrostatins, alone or in combination, for promoting axon regeneration and nerve function, thereby treating cns disorders
|
US8492556B2
(en)
|
2011-11-10 |
2013-07-23 |
Allergan, Inc. |
2,5-Dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (FPRL-1) receptor modulators
|
CA2871995A1
(en)
|
2012-05-04 |
2013-11-07 |
Novartis Ag |
Biomarkers for iap inhibitor therapy
|
SG11201408280YA
(en)
|
2012-06-26 |
2015-01-29 |
Biovalence Sdn Bhd |
Anticancer treatment
|
US20150185215A1
(en)
|
2012-07-02 |
2015-07-02 |
Cell Assay Innovations, Inc. |
Cell-Based Assays For Post-Translational Enzyme Activity
|
JPWO2014126127A1
(ja)
|
2013-02-13 |
2017-02-02 |
国立大学法人北海道大学 |
ネクロプトーシス関連疾患の治療用医薬組成物及びその有効成分のスクリーニング方法
|
TWI648273B
(zh)
|
2013-02-15 |
2019-01-21 |
英商葛蘭素史克智慧財產發展有限公司 |
作為激酶抑制劑之雜環醯胺類(三)
|
KR20150126882A
(ko)
|
2013-02-27 |
2015-11-13 |
더 브로드 인스티튜트, 인코퍼레이티드 |
T 세포의 균형 유전자 발현, 물질의 조성물 및 이의 사용 방법
|
WO2014152182A1
(en)
|
2013-03-15 |
2014-09-25 |
President And Fellows Of Harvard College |
Deuterated heterocyclic inhibitors of necroptosis
|
EP2968276A4
(en)
|
2013-03-15 |
2017-02-15 |
President and Fellows of Harvard College |
Hybrid necroptosis inhibitors
|
CN105189465B
(zh)
|
2013-03-21 |
2019-02-26 |
赛诺菲-安万特德国有限公司 |
合成含有乙内酰脲的肽产物
|
US20160051629A1
(en)
|
2013-04-15 |
2016-02-25 |
Yeda Research And Development Co. Ltd. |
Inhibition of rip kinases for treating lysosomal storage diseases
|
GB201316651D0
(en)
|
2013-09-19 |
2013-11-06 |
Univ Southampton |
Asthma
|
JP6389896B2
(ja)
|
2013-09-23 |
2018-09-12 |
カール・ツァイス・エスエムティー・ゲーエムベーハー |
多層ミラー
|
EP2857839A1
(en)
|
2013-10-01 |
2015-04-08 |
AIT Austrian Institute of Technology GmbH |
Breast cancer diagnostic method and means
|
US20150147780A1
(en)
|
2013-11-22 |
2015-05-28 |
World Biotechnology LLC |
Method for harvesting organic compounds from genetically modified organisms
|
WO2015095449A1
(en)
|
2013-12-19 |
2015-06-25 |
Ptc Therapeutics, Inc. |
Methods for modulating the amount rna transcripts
|
US10195202B2
(en)
|
2013-12-19 |
2019-02-05 |
Ptc Therapeutics, Inc. |
Methods for modulating the amount of RNA transcripts
|
WO2015105938A1
(en)
|
2014-01-08 |
2015-07-16 |
World Biotechnology LLC |
Genetically modified organisms to produce organic compounds
|
WO2015154197A1
(en)
|
2014-04-11 |
2015-10-15 |
Children's Hospital Of Eastern Ontario Research Institute Inc. |
Compositions and methods for glioblastoma treatment
|
EP3180014A1
(en)
|
2014-08-13 |
2017-06-21 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Prevention of tumour metastasis by inhibition of necroptosis
|
US20160045609A1
(en)
|
2014-08-14 |
2016-02-18 |
Mamoun M. Alhamadsheh |
Conjugation of pharmaceutically active agents with transthyretin ligands through adjustable linkers to increase serum half-life
|
WO2016044777A1
(en)
|
2014-09-18 |
2016-03-24 |
Abbvie Inc. |
Hat inhibitors and methods for their use
|
EP3017825A1
(en)
|
2014-11-06 |
2016-05-11 |
Ludwig-Maximilians-Universität München |
An inhibitor of the RIPK1-dependent necrosis pathway and a pharmaceutical composition comprising the same
|
TW201632516A
(zh)
|
2014-12-11 |
2016-09-16 |
哈佛大學校長及研究員協會 |
細胞壞死抑制劑與相關方法
|
AU2015371824B2
(en)
|
2014-12-24 |
2019-09-19 |
National Institute Of Biological Sciences, Beijing |
Necrosis inhibitors
|
WO2016101885A1
(en)
|
2014-12-24 |
2016-06-30 |
National Institute Of Biological Sciences, Beijing |
Necrosis inhibitors
|